WebDisclosure WebDisclosure
Basculer en Français
11086 Companies
243510 Keywords
171684 Articles
131186 Press releases
Headlines Articles Press releases EMBARC Remove
  1. Home
  2. Companies
  3. EMBARC
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/25/2026 at 11:10, 3 months 3 days ago

    EMBARC to Collaborate with Insmed on Brensocatib Study in Bronchiectasis

    Bronchiectasis Brensocatib EMBARC Insmed Collaboration Interventional Study
  • BRIEF

    published on 06/25/2026 at 11:10, 3 months 3 days ago

    EMBARC va collaborer avec Insmed sur une étude concernant le brensocatib dans la bronchectasie.

    Bronchectasie Brensocatib EMBARC Collaboration Insmed Étude Interventionnelle
  • PRESS RELEASE

    published on 06/25/2026 at 11:05, 3 months 3 days ago

    EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis

    EMBARC announces collaboration with Insmed on landmark interventional study evaluating disease modification potential of brensocatib in bronchiectasis. Study aims to enroll 3,000 patients across Europe
    Bronchiectasis EMBARC Interventional Study Insmed Disease Modification
    Logo of EMBARC
Accesswire
  • Published on 09/29/2026 at 02:30, 59 minutes ago

    QNX and neueHCT Join Forces to Accelerate Global Intelligent Driving Deployment, Anchored by Major German Automaker Program Win

  • Published on 09/29/2026 at 00:00, 3 hours 29 minutes ago

    Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial

  • Published on 09/28/2026 at 23:00, 4 hours 29 minutes ago

    CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives

  • Published on 09/28/2026 at 15:00, 12 hours 29 minutes ago

    Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia

  • Published on 09/28/2026 at 14:45, 12 hours 44 minutes ago

    Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

View all ACCESSWIRE
EQS Group
  • Published on 09/28/2026 at 22:14, 5 hours 15 minutes ago

    EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board

  • Published on 09/28/2026 at 19:24, 8 hours 4 minutes ago

    EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year

  • Published on 09/28/2026 at 19:00, 8 hours 29 minutes ago

    PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 21 septembre 2026 au 25 septembre 2026

  • Published on 09/28/2026 at 18:00, 9 hours 29 minutes ago

    GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)

  • Published on 09/28/2026 at 18:00, 9 hours 29 minutes ago

    GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026

View all EQS
Les Echos
  • Published on 09/28/2026 at 17:54, 9 hours 34 minutes ago

    Reporting on share buyback transactions carried out between September 21 and September 25, 2026

  • Published on 09/28/2026 at 17:54, 9 hours 34 minutes ago

    Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026

  • Published on 09/28/2026 at 17:45, 9 hours 44 minutes ago

    Weekly share buyback

  • Published on 09/28/2026 at 17:45, 9 hours 44 minutes ago

    Déclaration hebdomadaire de rachat d'actions

  • Published on 09/28/2026 at 17:35, 9 hours 54 minutes ago

    Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy